Description
Percentage of people under 40 years of age with relapsing-remitting MS receiving disease-modifying treatment. Disease-modifying treatments in MS aim to inhibit and limit the spread of inflammation in the central nervous system. Relapsing-remitting MS is characterized by the person experiencing periods of deterioration, so-called relapses.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Data service with information in Swedish | Unknown | Open resource |